With 26% Growth in H1, Neimeth Outshines Peers in Revenue Generation

Neimeth International Pharmaceuticals Plc emerged as the fastest-growing listed pharmaceutical company by revenue in the first half of 2026, recording a 26 per cent year-on-year increase in sales despite a

The Briefing Africa

August 10, 2026 · 01:23 · 5 min read

AI Summary

AI-generated summary · Highlight any paragraph below to share it as a branded quote card

Full analysis is being generated — check back shortly.

#Economy #Africa #BriefingAfrica #Breaking #Analysis

Confirmed by ThisDay + others

🇳🇬 ThisDay

🎙 The Panel — What Does This Mean?

4 perspectives

The court's directive to the NDLEA emphasizes the severity of Nigeria's methamphetamine issue, as the facility...

Many Nigerians are supportive of the court's decision, viewing it as a necessary action to tackle drug abuse a...

While the court's order is a positive move, it raises questions about the NDLEA's capacity and willingness to ...

To effectively combat methamphetamine production, the government should invest in community education and reha...

Share Quote as Image

PREVIEW PAGES

With 26% Growth in H1, Neimeth Outshines Peers in Revenue Generation